Drug General Information (ID: DDIZWT142G)
  Drug Name Ondansetron Drug Info Sevoflurane Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antiemetics Anesthetics
  Structure

 Mechanism of Ondansetron-Sevoflurane Interaction (Severity Level: Moderate)
     Increased risk of prolong QT interval Click to Show/Hide Mechanism Graph
Could Not Find 2D Structure
      Drug Name Ondansetron Sevoflurane
      Mechanism Prolong QT interval Prolong QT interval
      Key Mechanism Factor 1
Factor Name QT interval
Factor Description Long QT syndrome is a heart signaling disorder that can cause a fast, chaotic heartbeat (arrhythmia). Many people may not exhibit symptoms, and usually the condition is detected during routine medical tests. In others, the most common symptoms include: sudden fainting, palpitations, dizziness, seizures, sudden death.
      Mechanism Description
  • Increased risk of prolong QT interval by the combination of Ondansetron and Sevoflurane 

Recommended Action
      Management Caution is recommended if sevoflurane is used in combination with other drugs that can prolong the QT interval. The patient's cardiovascular status and serum electrolytes should be closely monitored.

References
1 Canadian Pharmacists Association.
2 Cerner Multum, Inc. "Australian Product Information.".
3 Cerner Multum, Inc. "UK Summary of Product Characteristics.".
4 Product Information. Ultane (sevoflurane). Abbott Pharmaceutical, Abbott Park, IL.